3ZGZ image
Deposition Date 2012-12-19
Release Date 2013-01-30
Last Version Date 2023-12-20
Entry Detail
PDB ID:
3ZGZ
Keywords:
Title:
Ternary complex of E. coli leucyl-tRNA synthetase, tRNA(leu) and toxic moiety from agrocin 84 (TM84) in aminoacylation-like conformation
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:LEUCINE--TRNA LIGASE
Gene (Uniprot):leuS
Chain IDs:A, C (auth: D)
Chain Length:880
Number of Molecules:2
Biological Source:ESCHERICHIA COLI
Polymer Type:polyribonucleotide
Molecule:TRNA-LEU UAA ISOACCEPTOR
Chain IDs:B, D (auth: E)
Chain Length:88
Number of Molecules:2
Biological Source:ESCHERICHIA COLI K-12
Primary Citation
Plant Tumour Biocontrol Agent Employs a tRNA-Dependent Mechanism to Inhibit Leucyl-tRNA Synthetase
Nat.Commun. 4 1417 ? (2013)
PMID: 23361008 DOI: 10.1038/NCOMMS2421

Abstact

Leucyl-tRNA synthetases (LeuRSs) have an essential role in translation and are promising targets for antibiotic development. Agrocin 84 is a LeuRS inhibitor produced by the biocontrol agent Agrobacterium radiobacter K84 that targets pathogenic strains of A. tumefaciens, the causative agent of plant tumours. Agrocin 84 acts as a molecular Trojan horse and is processed inside the pathogen into a toxic moiety (TM84). Here we show using crystal structure, thermodynamic and kinetic analyses, that this natural antibiotic employs a unique and previously undescribed mechanism to inhibit LeuRS. TM84 requires tRNA(Leu) for tight binding to the LeuRS synthetic active site, unlike any previously reported inhibitors. TM84 traps the enzyme-tRNA complex in a novel 'aminoacylation-like' conformation, forming novel interactions with the KMSKS loop and the tRNA 3'-end. Our findings reveal an intriguing tRNA-dependent inhibition mechanism that may confer a distinct evolutionary advantage in vivo and inform future rational antibiotic design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures